Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 186 transactions totaling $143.6M, demonstrating a bearish sentiment with -$33.3M in net insider flow. The most recent transaction on Jan 16, 2026 involved a transaction of 2,847 shares valued at $0.
AMLX Insider Activity Summary
Who Is Buying AMLX Stock?
No significant insider buying has been recorded for AMLX in the recent period.
Who Is Selling AMLX Stock?
No significant insider selling has been recorded for AMLX in the recent period.
Is Amylyx Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AMLX is bearish with an Insider Alignment Score of 38/100 and a net flow of -$33.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AMLX Frequently Asked Questions
Understanding AMLX Insider Activity
Insider trading at Amylyx Pharmaceuticals, Inc. (AMLX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading AMLX stock, having executed 186 transactions in the past 90 days. The most active insider is Global Opportunities Illiquid Investments Sub-master Lp Viking (Executive), who has made 18 transactions totaling $85.4M.
Related Tools
Track Amylyx Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at AMLX file new Form 4 transactions